Abstract: A battery cell includes a casing, an electrode assembly, a first insulating member and a second insulating member. The inner surface of a bottom wall of the casing is connected to the inner surface of a first side wall by a first arc transition surface; a first partition portion of the first insulating member separates the electrode assembly and the first side wall; the second insulating member separates the electrode assembly and the bottom wall; in the thickness direction of the second insulating member, the separator of the electrode assembly has a stacked part located between an electrode plate and the second insulating member; and the radius R1 of the first circular arc transition surface, the thickness a1 of the first partition portion, the thickness b of the stacked part and the thickness c of the second insulating member satisfy R1?(c+b)2+4(a1)2+[(a1)*(c+b)]1/2.

Abstract: In a method for efficiently inducing reprogramming of human cells into neuronal cells, a concentration of cAMP is increased or an expression of PKA and CREB is up-regulated or an expression of AMPK, ALK2, ALK3, P38, and JNK is inhibited by a single small molecule compound or gene knockout or gene overexpression. In the present disclosure, the induction small molecule compound is single and safe, and has a short induction time, high induction efficiency, definite induction sites and genes, and clear molecular regulation mechanism. The small molecule compound can be applied to the clinical treatment of human neurodegenerative diseases, providing a safer and more efficient treatment method for the neurodegenerative diseases. Since neuronal cells cannot divide and proliferate, the method induces fibroblasts and astrocytes that can divide and proliferate in vitro and in vivo, to continuously obtain a large number of induced neuronal cells in vitro and in vivo.

Abstract: The present invention provides an efficient method for mass-producing 2-hydroxy-5-(substituted)phenylalkylamino benzoic acid derivatives represented by specific Chemical formulas or their salts, particularly 2-hydroxy-5-[2-(4-trifluoromethylphenyl)ethylamino]benzoic acid or its salt.

Abstract: The present invention provides an efficient method for mass-producing 2-hydroxy-5-(substituted)phenylalkylaminobenzoic acid derivative represented by the specific Chemical formula or its salt, particularly 2-hydroxy-5-[2-(4-trifluoromethylphenyl)ethylamino] benzoic acid or its salt.

Abstract: A method for diagnosing a cell proliferative disease expressing DcR3/TR6 in a patient, which comprises the step of measuring the concentration of DcR3/TR6 in the patient's blood, plasma or serum sample, wherein a concentration of DcR3/TR6 higher than that present in the serum of a patient not suffering of a proliferative disease expressing DcR3/TR6 is indicative of that patient suffering from said disease. Methods of prognosing said diseases and compositions of matters for use in said diseases.